Explore the details of the Eli Lilly And Company V. Msn Laboratories Private Limited case under case number 1:23-cv-01277 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-01277
Filing Date
Nov 8, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
MSN Pharmaceuticals Inc. -
Incyte Corporation -
Eli Lilly and Company -

Patents Involved in the Case

There is a single patent involved in this case.

Application NumberPatent Number
-US8158616B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Nov 8, 2023Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,158,616 B2. (mpb) (Entered: 11/09/2023)PACER Document
Nov 8, 2023Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/4/2023. Date of Expiration of Patent: 6/8/2030.Thirty Month Stay Deadline: 4/4/2026. (mpb) (Entered: 11/09/2023)PACER Document
Nov 8, 2023Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 11/09/2023)PACER Document
Nov 8, 2023COMPLAINT filed against MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. ( Filing fee $ 402, receipt number ADEDC-4269671.) - filed by Incyte Corporation, Eli Lilly and Company, Incyte Holdings Corporation. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mpb) (Entered: 11/09/2023)PACER Document
Nov 14, 2023WAIVER OF SERVICE returned executed by Incyte Corporation, Eli Lilly and Company, Incyte Holdings Corporation: For MSN Laboratories Private Limited waiver sent on 11/13/2023, answer due 1/12/2024. (Tigan, Jeremy) (Entered: 11/14/2023)PACER Document
Nov 14, 2023WAIVER OF SERVICE returned executed by Incyte Corporation, Eli Lilly and Company, Incyte Holdings Corporation: For MSN Pharmaceuticals Inc. waiver sent on 11/13/2023, answer due 1/12/2024. (Tigan, Jeremy) (Entered: 11/14/2023)PACER Document
Nov 15, 2023STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) (Entered: 11/15/2023)PACER Document
Jan 11, 2024STIPULATION and [Proposed] Order to Consolidate by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Ekiner, Kaan) (Entered: 01/11/2024)PACER Document
Jan 17, 2024SO ORDERED, re (61 in 1:22-cv-01114-JLH, 11 in 1:23-cv-01277-JLH) Stipulation and Order to Consolidate C.A. No. 23-1277-JLH with C.A. No. 22-1114-JLH. Signed by Judge Jennifer L. Hall on 1/17/2024. Associated Cases: 1:22-cv-01114-JLH, 1:23-cv-01277-JLH(ceg) (Entered: 01/17/2024)PACER Document
Nov 15, 2023Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)PACER Document
Jan 12, 2024Case Reassigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. Associated Cases: 1:22-cv-01114-JLH, 1:22-cv-01115-JLH, 1:23-cv-01277-JLH (rjb)PACER Document
Jan 17, 2024Case associated with lead case: Create association to 1:22-cv-01114-JLH. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 1:22-cv-01114-JLH ONLY. (ceg)PACER Document